Status:
UNKNOWN
The Gut-lung Axis in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Peking University People's Hospital
Collaborating Sponsors:
Ningde City Hospital, Fujian, China
Conditions:
Pulmonary Disease, Chronic Obstructive
Microbiota
Eligibility:
All Genders
40+ years
Brief Summary
Patients with chronic obstructive pulmonary disease (COPD) are 2-3 times more likely to occur together with chronic gastrointestinal tract (GIT) diseases, such as inflammatory bowel disease (IBD) or i...
Eligibility Criteria
Inclusion
- admitted to hospital with an exacerbation of COPD;
- with no history of probiotics taken;
- the duration of antibiotics treatment before enrollment should be less than 72 hours.
Exclusion
- being immunocompromised, including history of glucocorticoid taken for more than 1 month, history of immunosuppressive therapy, history of human immunodeficiency virus (HIV) infection, solid tumor or hematological malignancy;
- history of long-term nursing home stays;
- history of recently hospitalized (\<90 days).
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03236480
Start Date
January 1 2017
End Date
January 1 2019
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044